文献速递脊柱关节炎

强直性脊柱炎放射学进展的预测因素

Factors Predictive of Radiographic Progression in Ankylosing Spondylitis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-01-04

该纵向观察队列纳入350例强直性脊柱炎患者,采用mSASSS评估脊柱放射学损伤,定义2年内mSASSS增加≥2单位为进展。结果显示男性、基线存在损伤、炎症标志物升高及TNFi使用可预测放射学进展,TNFi治疗使进展速率降低20%。

要点

  • 男性、基线存在损伤、CRP升高是放射学进展的预测因素。
  • TNFi使用与放射学进展速率降低20%相关。
  • 2年内mSASSS增加≥2单位定义为放射学进展。

核心结论

  • 男性、基线存在损伤、活动性疾病状态和较高炎症标志物提示放射学进展高风险。
  • TNFi治疗通过减缓放射学进展速率显示疾病修饰作用。

研究设计与样本

  • 纵向观察队列研究,纳入具有基线和随访颈椎及腰椎X线片的强直性脊柱炎患者350例。
  • 采用改良Stoke强直性脊柱炎脊柱评分(mSASSS)评估放射学损伤,定义2年内mSASSS变化≥2单位为进展。

主要发现

  • mSASSS均值±标准差从基线9.3±15.8单位增至第6年17.7±21.7单位。
  • 第0-2年、2-4年、4-6年间mSASSS均值±标准差变化分别为1.23±2.68、1.47±2.86、1.52±3.7单位。
  • 总体24.3%的患者在2年内出现进展。
  • 男性(HR 2.46 [95%CI 1.05, 5.76])、基线存在损伤(HR 7.98 [95%CI 3.98, 16])、log C反应蛋白水平升高(HR 1.35 [95%CI 1.07, 1.70])和TNFi使用(HR 0.82 [95%CI 0.70, 0.96])可预测放射学进展。
  • TNFi治疗使进展速率降低20%。

关键数值与推荐

  • 放射学进展定义为2年内mSASSS变化≥2单位。
  • 基线存在损伤的HR为7.98(95%CI 3.98, 16)。
  • 男性HR为2.46(95%CI 1.05, 5.76)。
  • log C反应蛋白水平HR为1.35(95%CI 1.07, 1.70)。
  • TNFi使用HR为0.82(95%CI 0.70, 0.96)。

临床怎么用

  • 对男性、基线已有放射学损伤、CRP升高或疾病活动度高的强直性脊柱炎患者应警惕放射学进展风险。
  • TNFi治疗可能减缓放射学进展,支持其疾病修饰作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Using a longitudinal observational cohort of ankylosing spondylitis (AS) patients, we sought to identify progression rates and factors predictive of spinal progression. As a secondary aim, we analyzed the effect of tumor necrosis factor inhibitor (TNFi) treatment on radiographic progression. METHODS: AS patients who had baseline and follow-up cervical and lumbar radiographs were included in the study. Radiographic damage was assessed by the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). A change of 2 mSASSS units in 2 years was defined as progression. The characteristics of the study group such as demographic, clinical, laboratory, and treatment history were collected. RESULTS: There were 350 patients in the study. The mean ± SD mSASSS increased from 9.3 ± 15.8 units at baseline to 17.7 ± 21.7 units by the sixth year. Mean ± SD changes in mSASSS between the years 0 to 2, 2 to 4, and 4 to 6 were 1.23 ± 2.68, 1.47 ± 2.86, and 1.52 ± 3.7 units, respectively. Overall, 24.3% of the group progressed over 2 years. Male sex (hazard ratio [HR] 2.46 [95% confidence interval (95% CI) 1.05, 5.76]), the presence of baseline damage (HR 7.98 [95% CI 3.98, 16]), increased inflammatory markers (log C-reactive protein level HR 1.35 [95% CI 1.07, 1.70]), and TNFi use (HR 0.82 [95% CI 0.70, 0.96]) were predictive of radiographic progression. There was a 20% reduction in the rate of progression with TNFi. CONCLUSION: Male sex, the presence of baseline damage, active disease state, and higher inflammatory markers confer a high risk for disease progression. Treatment with TNFi showed a disease-modifying effect by slowing the rate of radiographic progression.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Sari I, Lee S, Tomlinson G, et al. Factors Predictive of Radiographic Progression in Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2021. PMID: 31675169. doi:10.1002/acr.24104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。